Director/PDMR Shareholding

Assura PLC

12 July 2024

 

12 July 2024

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons

Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 8 July 2024, the following named PDMRs were granted the following share options over Ordinary Shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").

PDMR	Position	Number of Share Options Granted
Jonathan Murphy	CEO	1,905,505
Jayne Cottam	CFO	1,269,599

These options are subject to three performance conditions which will be determined after the 2026/27 financial year.  33% of the option shares are subject to a Total Shareholder Return ("TSR") performance condition, 33% of the option shares are subject to a Total Accounting Return ("TAR") performance condition and the remaining 33% are subject to ESG measures related to portfolio energy reduction targets (energy usage intensity, "EUI") and net zero carbon developments.  Details of the performance conditions are set out in the Company's Directors' Remuneration Report for 2023/24.

In addition, the following PDMRs were granted restricted share options over Ordinary Shares of 10 pence each in the company under the PSP.

PDMR	Position	Number of Restricted Share Options Granted
Orla Ball	General Counsel	88,474
Robert James	Group Development Director	88,474
Sarah Taylor	Chief People Officer	88,474

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jonathan Murphy
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options over ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Grant of options under the PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 1,905,505
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £NIL GBP 1,905,505 £NIL GBP
e)	Date of the transaction	08/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options over ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Grant of options under the PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 1,269,599
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £NIL GBP 1,269,599 £NIL GBP
e)	Date of the transaction	08/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Orla Ball
2	Reason for the notification
a)	Position/status	General Counsel
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options over ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Grant of restricted share options under the PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 88,474
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £NIL GBP 88,474 £NIL GBP
e)	Date of the transaction	08/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Robert James
2	Reason for the notification
a)	Position/status	Group Development Director
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options over ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Grant of restricted share options under the PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 88,474
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £NIL GBP 88,474 £NIL GBP
e)	Date of the transaction	08/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Sarah Taylor
2	Reason for the notification
a)	Position/status	Chief People Officer
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options over ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Grant of restricted share options under the PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 88,474
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £NIL GBP 88,474 £NIL GBP
e)	Date of the transaction	08/07/2024
f)	Place of the transaction	XLON

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, General Counsel David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson Grace Whelan	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

END